Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis
Clinical trial NCT05556746 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05556746
- Sponsor
- Brigham and Women's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-24
- Primary completion
- 2025-06-12
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.